REFERENCES
1. Regente M, Corti-Monzón G, Maldonado AM, Pinedo M, Jorrín J, de la Canal L. Vesicular fractions of sunflower apoplastic fluids are associated with potential exosome marker proteins. FEBS Lett. 2009;583:3363-6.
2. An Y, Sun JX, Ma SY, et al. From plant based therapy to plant-derived vesicle-like nanoparticles for cancer treatment: past, present and future. Int J Nanomedicine. 2025;20:3471-91.
3. Chi J, Wang X, Song Y, et al. Emerging plant-derived exosome-like particles reveal key therapeutic benefits. A comprehensive review of evidence. Int J Nanomedicine. 2025;20:12393-411.
4. Cheng Z, Lu W, Shao W, et al. Advances in plant-derived vesicle like nanoparticles-based therapies for inflammatory diseases. Asian J Pharm Sci. 2025;20:101052.
5. Feng H, Yue Y, Zhang Y, et al. Plant-derived exosome-like nanoparticles: emerging nanosystems for enhanced tissue engineering. Int J Nanomedicine. 2024;19:1189-204.
6. Feng Z, Huang J, Fu J, Li L, Yu R, Li L. Medicinal plant-derived exosome-like nanovesicles as regulatory mediators in microenvironment for disease treatment. Int J Nanomedicine. 2025;20:8451-79.
7. Tembo KM, Wang X, Bolideei M, et al. Exploring the bioactivity of microRNAs originated from plant-derived exosome-like nanoparticles (PELNs): current perspectives. J Nanobiotechnol. 2025;23:563.
8. Hao S, Yang H, Hu J, Luo L, Yuan Y, Liu L. Bioactive compounds and biological functions of medicinal plant-derived extracellular vesicles. Pharmacol Res. 2024;200:107062.
9. Zeng M, Liu M, Tao X, Yin X, Shen C, Wang X. Emerging trends in the application of extracellular vesicles as novel oral delivery vehicles for therapeutics in inflammatory diseases. Int J Nanomedicine. 2024;19:8573-601.
10. Che K, Wang C, Chen H. Advancing functional foods: a systematic analysis of plant-derived exosome-like nanoparticles and their health-promoting properties. Front Nutr. 2025;12:1544746.
11. Yang N, Wang Y, Liu H, Li T, Lu M, Lu R. Plant-derived extracellular vesicles in facial aesthetics. Extracell Vesicles Circ Nucl Acids. 2025;6:651-68.
12. Zhao B, Lin H, Jiang X, et al. Exosome-like nanoparticles derived from fruits, vegetables, and herbs: innovative strategies of therapeutic and drug delivery. Theranostics. 2024;14:4598-621.
13. Bai C, Liu J, Zhang X, et al. Research status and challenges of plant-derived exosome-like nanoparticles. Biomed Pharmacother. 2024;174:116543.
14. Mu N, Li J, Zeng L, et al. Plant-derived exosome-like nanovesicles: current progress and prospects. Int J Nanomedicine. 2023;18:4987-5009.
15. Kim J, Li S, Zhang S, Wang J. Plant-derived exosome-like nanoparticles and their therapeutic activities. Asian J Pharm Sci. 2022;17:53-69.
16. Xu G, Jin J, Fu Z, et al. Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies. Signal Transduct Target Ther. 2025;10:255.
17. Greening DW, Xu R, Rai A, Suwakulsiri W, Chen M, Simpson RJ. Clinical relevance of extracellular vesicles in cancer - therapeutic and diagnostic potential. Nat Rev Clin Oncol. 2025;22:924-52.
18. Li Z, Wang H, Yin H, Bennett C, Zhang HG, Guo P. Arrowtail RNA for ligand display on ginger exosome-like nanovesicles to systemic deliver siRNA for cancer suppression. Sci Rep. 2018;8:14644.
19. Kim J, Zhu Y, Chen S, et al. Anti-glioma effect of ginseng-derived exosomes-like nanoparticles by active blood-brain-barrier penetration and tumor microenvironment modulation. J Nanobiotechnol. 2023;21:253.
20. Chen Q, Li Q, Liang Y, et al. Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation. Acta Pharm Sin B. 2022;12:907-23.
21. Chen L, Zu M, Cao Y, et al. Oral plant-derived nanomedicines mitigate acetaminophen-induced liver injury by modulating the gut-liver axis and intestinal microbiota metabolism. Small. 2025;21:e2502001.
22. Wang S, Jiang T, Jiang M, Miao YB. Leveraging polysaccharide-derived nanocarriers to open new horizons in oral vaccine activation. Mater Today Bio. 2025;35:102300.
23. Liu Y, Liu C, An D, Deng S, Liu G. Engineered nanomaterials for overcoming multifaceted gastrointestinal barriers: toward precision oral delivery of therapeutics. Pharmacol Res. 2025;218:107844.
25. Haroon HB, Dhillon E, Farhangrazi ZS, Trohopoulos PN, Simberg D, Moghimi SM. Activation of the complement system by nanoparticles and strategies for complement inhibition. Eur J Pharm Biopharm. 2023;193:227-40.
26. Gao Z, Li J, Yang W, et al. Plant-derived exosome-like nanoparticles: innovative nanomedicine for therapeutic applications. Food Sci Nutr. 2025;13:e70974.
27. Olugbodi JO, Lawal B, Bako G, et al. Effect of sub-dermal exposure of silver nanoparticles on hepatic, renal and cardiac functions accompanying oxidative damage in male Wistar rats. Sci Rep. 2023;13:10539.
28. Brodin BA, Saladino GM, Hertz HM, Arsenian-Henriksson M, Toprak MS. Innate immuno-response to nanoparticle uptake in liver and spleen mimics pathogen infection. Nanomedicine. 2025;20:2721-31.
29. Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Delivery Rev. 2016;99:28-51.
30. Zhang J, Tian S, Guo L, Zhao H, Mao Z, Miao M. Chinese herbal medicine-derived extracellular vesicles as novel biotherapeutic tools: present and future. J Transl Med. 2024;22:1059.
31. Eii MN, Walpole S, Aldridge C. Sustainable practice: prescribing oral over intravenous medications. BMJ. 2023;383:e075297.
32. Cheng H, Liao J, Ma Y, Sarwar MT, Yang H. Advances in targeted therapy for tumor with nanocarriers: a review. Mater Today Bio. 2025;31:101583.
33. Fang Z, Liu K. Plant-derived extracellular vesicles as oral drug delivery carriers. J Control Release. 2022;350:389-400.
34. Chen X, Xing X, Lin S, et al. Plant-derived nanovesicles: harnessing nature’s power for tissue protection and repair. J Nanobiotechnol. 2023;21:445.
35. Zhang M, Viennois E, Prasad M, et al. Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016;101:321-40.
36. Kim J, Sim Y, Kim D, et al. Ginseng-derived exosome-like nanovesicles protect against liver fibrosis by regulating TIMP2 pathways and gut dysbiosis. Asian J Pharm Sci. 2025;20:101105.
37. Teng Y, Luo C, Qiu X, et al. Plant-nanoparticles enhance anti-PD-L1 efficacy by shaping human commensal microbiota metabolites. Nat Commun. 2025;16:1295.
38. Sha A, Luo Y, Xiao W, et al. Plant-derived exosome-like nanoparticles: a comprehensive overview of their composition, biogenesis, isolation, and biological applications. Int J Mol Sci. 2024;25:12092.
39. Song Y, Feng N, Yu Q, et al. Exosomes in disease therapy: plant-derived exosome-like nanoparticles current status, challenges, and future prospects. Int J Nanomedicine. 2025;20:10613-44.
40. Li Y, Wang Y, Zhao H, Pan Q, Chen G. Engineering strategies of plant-derived exosome-like nanovesicles: current knowledge and future perspectives. Int J Nanomedicine. 2024;19:12793-815.
41. Huang F, Shao X, Geng X, Wang Q. Interpretation of guidance on non-clinical safety evaluation for nanomedicines. Acta Pharm Sin. 2023;58:805-14.
42. Chenthamara D, Subramaniam S, Ramakrishnan SG, et al. Therapeutic efficacy of nanoparticles and routes of administration. Biomater Res. 2019;23:20.
43. Dad HA, Gu TW, Zhu AQ, Huang LQ, Peng LH. Plant exosome-like nanovesicles: emerging therapeutics and drug delivery nanoplatforms. Mol Ther. 2021;29:13-31.
44. Wang S, Zhang Y, Zeng Y, et al. Plant-derived vesicle-like nanoparticles for immunomodulation: Mechanisms and applications. Bioact Mater. 2026;55:171-204.
